The invention discloses a method for measuring the concentration of molecular targeted drugs in
plasma by using ultra-
high performance liquid chromatography tandem mass spectrometry. The method comprises the following steps of respectively dissolving anlotinib,
ceritinib and
ibrutinib by adopting
acetonitrile in order to prepare a
standard curve working solution, and dissolving
diazepam by adopting
methanol in order to prepare an
internal standard substance working solution; respectively adding 0-5 microliters of
standard curve working solution into blank
plasma to make up to 50 microliters, carrying out vortex to prepare a
standard curve plasma sample, adding the
internal standard substance working solution, carrying out vortex and
centrifugation, taking supernate, carrying out UPLC-MS / MSquantitative analysis, and drawing a standard curve; and precisely sucking to-be-detected plasma with the concentration of 50 microliters, adopting the same sample
pretreatment method, and measuringthe concentration of the anlotinib, the
ceritinib and the
ibrutinib according to a standard curve of the batch. According to the method, the
blood concentration of various anti-tumor molecular targeted drugs can be measured simultaneously, the method is high in sensitivity, strong in specificity, rapid and good in reproducibility and is suitable for clinical high-
throughput simultaneous detectionand monitoring of various anti-tumor molecular targeted drugs.